Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
CARLSBAD, Calif., July 07, 2017 -- SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announces a partnership with SkinSpirit, a recognized leader and expert in advanced aesthetic skin and body care treatments.
|
|||||
"We are thrilled to have SENTÉ products offered to patients in the impressive network of SkinSpirit clinics," said Laurent Combredet, President and Chief Executive Officer of SENTÉ. “SkinSpirit embodies everything SENTÉ thrives for, including exceptional patient outcomes, innovative skincare offerings and a strong emphasis on customer service.”
Since opening in 2003, SkinSpirit has since experienced significant growth and become one of the top destinations for aesthetic skin and body care in the country, with eight locations based in California and Washington.
"We spend a lot of time researching new skincare lines to find the best new products to make your skin look and feel great,” said Michael Dean Vistnes, MD, FACS, Founder and Medical Director of SkinSpirit. “SENTÉ fills the void in current skincare offerings by taking advantage of the latest science-backed evidence supporting the many incredible benefits of heparan sulfate."
About SENTÉ:
SENTÉ is a privately held specialty aesthetics company leveraging its expertise and foundation in biotechnology to deliver novel, science-based skin care products. SENTÉ is a recognized leader in the development of innovative and targeted skincare products based on glycosaminoglycans. Founded in 2007 and based in San Diego, California, further information may be found at sentelabs.com. SENTÉ products are available through its exclusive network of physicians and medically supervised spas.
About SkinSpirit
SkinSpirit is recognized as a leader and expert in the most effective skincare treatments for the face and body. The expert SkinSpirit team is led by Dr. Michael Dean Vistnes and Dr. Richard Baxter, who provide ongoing training in the newest techniques, ensuring the best care and results. Contact any one of our eight locations in the San Francisco Bay Area and Seattle Area to learn more or make an appointment. More information can be found at skinspirit.com.
Media Contact: Creative Media Marketing Danielle Hale [email protected] p: 212.979.8884 ext. 213
